Viewing Study NCT00035256


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2026-04-22 @ 5:55 AM
Study NCT ID: NCT00035256
Status: COMPLETED
Last Update Posted: 2007-05-15
First Post: 2002-05-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoporosis, Postmenopausal View
Keywords: